According to a filing with the Securities and Exchange Commission today, Elting is departing as an executive and employee of Orthofix Medical (Nasdaq: OFIX) in a mutual separation agreement. She did not disclose her next move in medtech.
Elting joined the Lewisville, Texas-based company in September 2016 as chief legal officer. She was promoted to chief legal and development officer in July 2022 and moved up to president of global orthopedics in April 2022.
Before her stint at Orthofix, she held roles with varying degrees of responsibility at TriVascular Technologies, St. Jude Medical and Jones Day.
More executive changes at Orthofix
Earlier this week, the company announced that it appointed Aviva McPherron as president of its global operations and quality. McPherron will oversee strategy for the company’s operations, manufacturing, regulatory, clinical and quality teams.
Her appointment follows a series of executive moves from Orthofix in recent months. Last week, the company appointed Julie Dewey as its new chief investor relations and communications officer. Max Reinhardt was also named president of the company’s global spine business.
Last fall, the company terminated a trio of executives with cause. Orthofix cut ties with CEO Keith Valentine, CFO John Bostjancic and chief legal officer Patrick Keran following an investigation.
The company then picked former LimaCorporate CEO Massimo Calafiore as its next CEO in November. In January, Julie Andrews took over as CFO, followed by the appointment of Andres Cedron as chief legal officer in April.
